Ippei Otomaru¹, Teruhito Takakuwa¹, Yoshimi Miyagi², Ayano Nishiura¹, Akiko Miura¹, Taku Araki¹, Yotaro Fujitani¹, Ryosuke Yamamura¹, Hideto Senzaki², Kensuke Ohta¹ (1.Hematology, Osaka Saiseikai Nakatsu Hospital, Japan, 2.Pathology, Osaka Saiseikai Nakatsu Hospital, Japan)

Saori Ito, Akinori Oh, Junpei Soeda (Japan Medical Affairs, Takeda Pharmaceuticals Company Limited, Tokyo, Japan)

Ryosuke Fujiwara^1,23, Hirokazu Tanaka^1,23, Kentaro Serizawa^1,23, Hitomi Kaneko^2,23, Yuji Shimura^3,23, Kensuke Ohta^4,23, Shin-Ichi Fuchida^5,23, Aya Nakaya^6,23, Junya Kanda^7,23, Hideo Yagi^8,9,23, Katsuya Wada^10,23, Satoru Kosugi^11,23, Nobuhiko Uoshima^12,23, Hirohiko Shibayama^13,23, Takae Kohara^13,23, Eiji Nakatani^14,23, Hitoji Uchiyama^15,23, Yoko Adachi^16,23, Masato Iida^17,23, Tsuneyoshi Hamada^18,23, Mitsuhiro Matsuda^19,23, Akifumi Takaori-Kondo^7,23, Shosaku Nomura^20,23, Chihiro Shimazaki^5,23, Masayuki Hino^21,23, Junya Kuroda^4,23, Masafumi Taniwaki^22,23, Kazunori Imada^2,23, Yuzuru Kanakura^13,23, Itaru Matsumura^1,23 (1.Hematolog and Rheumatology, Kindai University, Osaka, Japan, 2.Hematology, Osaka Red Cross Hospital, Osaka, Japan, 3.Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 5.Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 6.Hematology and Oncology, Kansai Medical University Medical Center, Osaka, Japan, 7.Hematology and Oncology, Kyoto University, Kyoto, Japan, 8.Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan, 9.Hematology, Kindai University Nara Hospital, 10.Hematology, Matsushita Memorial Hospital, Osaka, Japan, 11.Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 12.Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 13.Hematology and Oncology, Osaka University, Osaka, Japan, 14.Biostatistics and Data Science, Osaka University, Osaka, Japan, 15.Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 16.Hematology, Kobe Central Hospital, Hyogo, Japan, 17.Internal Medicine, Kawasaki Hospital, Hyogo, Japan, 18.Hematology, Kyoto-Katsura Hospital, Kyoto, Japan, 19.Hematology, PL General Hospital, Osaka, Japan, 20.First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 21.Hematology, Osaka City University, Osaka, Japan, 22.Molecular Diagnostics Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 23.Kansai Myeloma Forum, Osaka, Japan)

Koichiro Minauchi, Naoki Miyashita, Hajime Senjo, Shinpei Harada, Tomohiro Yamakawa, Junko Iwasaki, Shojiro Takahashi, Kohei Okada, Akio Shigematsu, Shuichi Ota, Masahiro Ogasawara, Naoki Kobayashi, Masahiro Imamura (Department of Hematology, Sapporo Hokuyu Hospital, Japan)

Masato Komuro¹, Shotaro Hagiwara², Naoki Kondo¹, Tomiteru Togano¹, Junji Tanaka², Hiroyuki Terakado¹ (1.National Center for Global Health and Medicine, Tokyo, Japan, 2.Tokyo Women's Medical University, Tokyo Japan)

Xuzhang Lu¹, Xueyi Yu¹, Zhuxia Jia¹, Wenmin Han¹, Jinyuan He¹, Rong Xiao¹, Xiaohui Cai¹, Ayaz Li², Weiya Wang¹, Xiaolong Fan² (1.The Affiliated Changzhou No.2 People's Hosptial of Nanjin Medical University, Changzhou, People's Republic of China, 2.Beijin Normal University, Beijing, People's Republic of China)

Pavel Kotoucek¹, Roumen Bezergianov², Robert Enright³, Waseem Nagi¹, Zuzana Ondrusova⁴, Alberto Orfao⁵, Zdenka Stefanikova⁴, Jan Sedlak⁶ (1.Mid Essex Hospital Services NHS Trust, Broomfield Hospital, Chelmsford, United Kingdom of Great Britain and Northern Ireland, 2.Counseling Services, Arizona State University, Phoenix, United States of America, 3.Educational Psychology, University of Wisconsin-Madison, Madison, United States of America, 4.Slovak Myeloma Society, Bratislava, Slovak Republic, 5.Salamanca Cancer Centre, Salamanca, Spain, 6.Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovak Republic)